Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Aptuit not selling stake in Laurus

29-Mar-2010

Related topics: Globalisation, Contract Manufacturing, Bulk ingredients

US CDMO Aptuit says its stake in Indian JV Aptuit Laurus unit is not for sale, scotching speculation that Swiss life-sciences supplier Lonza was interested in making a bid.

In a statement last week, the contract development and manufacturing organisation (CDMO) said that the story, reported in India’s Business Standard, “[is] based on rumors and there are no current discussions about a sale of these assets.”

"We wish to reiterate our long-term commitment to the relationship with Aptuit Laurus that we established several years ago, as well as our overall commitment to the Indian market."

Aptuit owns 51 per cent of Aptuit Laurus, while joint venture partner Laurus Labs owning the remainder of the firm. The unit has a turnover of around 2.50bn rupees ($55m),

Follow us on